Results 101 to 110 of about 458,290 (296)
Rational application of tumor marker CA 125 in gynecological oncology
Introduction CA 125 determination started in 1981, when Bast et al. discovered monoclonal antibody OC-125 belonging to immunoglobulin G class (IgG1) using K?hler and Milstein's technique of hybridization.
Sanja Stojanovic +3 more
core +1 more source
Our coaxial electrospinning system is capable of incorporating decellularized myocardial extracellular matrix in a core‐sheath configuration, creating nanofibrous scaffolds. These scaffolds, in turn, support the maintenance of functional cardiomyocytes adhered to the surface of these bioactive scaffolds.
Dhanusha N. Rajapakse +9 more
wiley +1 more source
Design and Synthesis of Peptide‐Polyester Conjugates for Cell‐Mediated Scaffold Degradation
This work describes polycaprolactone (PCL)‐based biomaterials engineered to degrade in response to cell‐secreted proteases. A fast‐degrading peptide (Fast) sequence is integrated into a PCL conjugate backbone to produce a biomaterial that is selectively degraded by multiple cell types compared to its scrambled control (ScrFast).
Korina Vida G. Sinad +7 more
wiley +1 more source
Objective. To investigate the serum level of CA-125 and its corresponding clinical significance in Chinese patients with primary BCS. Methods. Serum CA-125 was measured in 243 patients with primary BCS receiving interventional treatment in the ...
De-lei Cheng +5 more
doaj +1 more source
Microgel‐based 3D printed constructs represent a compelling and versatile innovation for engineering architecturally complex, dynamically remodelable, and biocompatible structures with high structural fidelity and bioactivity. By integrating material design, biofabrication, and biological function, these systems enable the development of adaptive ...
Elena Ghighină +2 more
wiley +1 more source
Introduction: Ovarian cancer is a neoplasm characterised by considerable mortality. The aim of numerousstudies which have been conducted is to determine the impact of clinical and biochemical parameters onovarian cancer prognosis, survival and treatment.
Wiesława Bednarek +4 more
doaj
Kalp yetersizliği olan hastalarda CA 125, CA 19-9, CA 15-3, CEA ve AFP'nin değerlendirilmesi
Kronik kalp yetersizliği olan hastalarda CA 125, CA 19-9, CA 15-3, CEA, AFP'nin değerlendirilmesi Amaç: Kalp yetersizliği (KY) olan hastalarda serumda tümör markerlarının düzeylerinin arttığı ileri sürülmektedir.
Tekin, Gülaçan Özgün
core
Surgical staging in early-stage uterine cancer is controversial. Preoperative serum CA-125 may be of clinical value in predicting the presence of extra-uterine disease in patients with apparent early-stage endometrial cancer. Between October 6, 2005, and
Nascimento, M. +34 more
core +1 more source
Atomic Layer Deposition Processes: Versatile Platforms for Engineering ZnO‐Chitosan Biointerfaces
Vapour phase metalation (VPM), multiplied pulsed vapour phase infiltration (MPI), and O2 plasma‑enhanced atomic layer deposition (PEALD) tailor Zn–chitosan (Zn‑CS) films. PEALD improves wettability and biocompatibility. MPI enhances semiconductor behavior. Antiseptic selectivity: VPM → E. coli; MPI → H. pylori.
Mabel Moreno +17 more
wiley +1 more source
The role of CA 125 in screening for ovarian cancer
Ovarian cancer has the worst prognosis of any gynaecological malignancy, primarily because it tends to present at an advanced stage. The excellent survival rates of early stage disease have provided the rationale for efforts to detect ovarian cancer ...
I.J. Jacobs +3 more
core +2 more sources

